Physician profile
Leah E Conant
NPI 1497275457
$10,199.76
in general payments reported to CMS, 2019-2025
9 companies · $6,426 in 2025
The $6,426 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.54 · 2020: $1,991 · 2022: $14.15 · 2023: $64.50 · 2024: $1,642 · 2025: $6,426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,162 · Food and Beverage: $2,461 · Education: $1,500 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,162.41 |
| Food and Beverage | $2,461.37 |
| Education | $1,500.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,220.36 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $3,626.02 | 2025 | Phasix Mesh, Arista |
| W. L. Gore & Associates, INC. | $886.43 | 2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Medtronic, INC. | $221.78 | 2022-2025 | Signia |
| Abbott Laboratories | $147.40 | 2024 | 2nd Gen Centrimag Primary Console |
| Boston Scientific Corporation | $35.76 | 2024 | Spyglass Discover |
| Lifenet Health | $21.19 | 2024 | Theragenesis Wound Matrix |
| Tela Bio, INC. | $20.52 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Conmed Corporation | $20.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Conant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.